Description
TRKA Protein Active (440-end)
| Catalog number: | B2013823 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 ug |
| Molecular Weight or Concentration: | 66 kDa |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | DKFZp781l14186, MTC, NTRK1, TRK1, p140-TrKA |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Reichardt LF. Neurotrophin-regulated signalling pathways Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1545-64.
- Minnone G, De Benedetti F, Bracci-Laudiero L. NGF and Its Receptors in the Regulation of Inflammatory Response Int J Mol Sci. 2017 May 11;18(5):1028.
- Amatu A, Sartore-Bianchi A, Siena S. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types ESMO Open. 2016 Mar 18;1(2):e000023.
- Fahnestock M, Shekari A. ProNGF and Neurodegeneration in Alzheimers Disease Front Neurosci. 2019 Feb 22;13:129.
- Zanin N, Blouin CM. [Endosomal control of intracellular signaling] Biol Aujourdhui. 2018;212(1-2):45-51.
- Hassiepen C, Soni A, Rudolf I, Boron V, Oeck S, Iliakis G, Schramm A. NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation Cancers (Basel). 2021 Nov 30;13(23):6023.
- Tsuruda A, Suzuki S, Maekawa T, Oka S. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells FEBS Lett. 2004 Feb 27;560(1-3):215-20.
- Lange AM, Lo HW. Inhibiting TRK Proteins in Clinical Cancer Therapy Cancers (Basel). 2018 Apr 4;10(4):105.
- Duan L, Hope JM, Guo S, Ong Q, Franois A, Kaplan L, Scherrer G, Cui B. Optical Activation of TrkA Signaling ACS Synth Biol. 2018 Jul 20;7(7):1685-1693.
